Earnings Call · Q4 FY2024·2025-03-13

Q4 24EPS +6.86%·Rev n/aQ3 24EPS -6.36%·Rev n/aQ2 24EPS +19.85%·Rev n/aQ1 24EPS -6.35%·Rev n/a⚠ consensus missing

REGENXBIO Inc. RGNX

Patrick Christmas — Investor Relations or Communications Officer

Curran Simpson — Chief Executive Officer

Steve Pakola — Chief Medical Officer

Mitchell Chan — Chief Financial Officer

+2.6%1d on move date+0.5% vs SPY3d+19.1%5d+27.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RGNX calls or request research access.

More RGNX calls Browse calls Request research access